BIOGEN INC | 233.40 / +5.21% |
Date/Time | 03/08 / 17:32 |
Chg. / Chg.(%) | 11.55 / +5.21% |
Bid | - |
Ask | - |
Open | 225.20 |
Previous Close | 221.85 |
High | 233.40 |
Low | 224.85 |
Volume [EUR] | 62,591.35 |
Volume [Units] | 275 |
Price fixings | 16 |
ISIN | US09062X1037 |
Security | BIIB |
Exchange | Vienna Global Market |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
NASDAQ | 270.0100 | ![]() |
1,163,675 |
IEX | 270.20 | ![]() |
65,885 |
Cboe US | 270.20 | ![]() |
56,356 |
London Inter.. | 277.18 | ![]() |
1,308 |
Xetra | 233.05 | ![]() |
1,176 |
TradeGate | 230.450 | ![]() |
1,014 |
Vienna Globa.. | 233.40 | ![]() |
275 |
gettex | 229.500 | ![]() |
52 |
Stuttgart | 233.050 | ![]() |
48 |
Frankfurt | 231.9000 | ![]() |
26 |
München | 232.30 | ![]() |
20 |
Berlin | 233.30 | ![]() |
14 |
Hamburg | 226.15 | ![]() |
0 |
Düsseldorf | 233.60 | ![]() |
0 |
Hannover | 226.15 | ![]() |
0 |
Lang & Schwa.. | 223.450 | ![]() |
|
Moscow | 20,276.00 | 556 | |
Mexico | 5,571.19 | ![]() |
73 |
News
- Catalyst Biosciences Reports Fourth Quarter and Full-Year 2020 Operating & Financial Results and Provides a Corporate Update
03/04/2021 / 14:00 - GlobeNewswire - Biogen Announces Plans to Build a New, State-of-the-Art Gene Therapy Manufacturing Facility in Research Triangle Park, North Carolina
03/04/2021 / 13:47 - GlobeNewswire - Dyne Therapeutics Appoints Wildon Farwell, M.D., MPH, as Chief Medical Officer
03/04/2021 / 13:25 - GlobeNewswire - Purple Biotech Appoints Biopharmaceutical Industry Veteran Robert Gagnon to Board of Directors
03/03/2021 / 13:00 - GlobeNewswire - Artizan Biosciences Closes $11 Million Series A-2 Financing and Enters Option and License Agreement with Biohaven Therapeutics
03/01/2021 / 22:00 - GlobeNewswire